Advertisement
Advertisement

MNOV

MNOV logo

Medicinova, Inc.

1.31
USD
Sponsored
+0.06
+4.80%
Jun 16, 15:58 UTC -4
Closed
exchange

After-Market

1.30

-0.01
-0.38%

MNOV Earnings Reports

Positive Surprise Ratio

MNOV beat 30 of 40 last estimates.

75%

Next Report

Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$44.20K
/
-$0.06
Implied change from Q1 26 (Revenue/ EPS)
-76.36%
/
+20.00%
Implied change from Q2 25 (Revenue/ EPS)
-67.16%
/
-14.29%

Medicinova, Inc. earnings per share and revenue

On May 14, 2026, MNOV reported earnings of -0.05 USD per share (EPS) for Q1 26, beating the estimate of -0.07 USD, resulting in a 29.97% surprise. Revenue reached 186.98 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a -1.43% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.06 USD, with revenue projected to reach 44.20 thousand USD, implying an increase of 20.00% EPS, and decrease of -76.36% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Medicinova, Inc. reported EPS of -$0.05, beating estimates by 29.97%, and revenue of $186.98K, 0% as expectations.
The stock price moved down -1.43%, changed from $1.40 before the earnings release to $1.38 the day after.
The next earning report is scheduled for Aug 11, 2026.
Based on -- analysts, Medicinova, Inc. is expected to report EPS of -$0.06 and revenue of $44.20K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement